Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts.
about
Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentialsRegulation of gene expression in osteoblasts.Lef1 haploinsufficient mice display a low turnover and low bone mass phenotype in a gender- and age-specific mannerAbdominal Fat and Sarcopenia in Women Significantly Alter Osteoblasts Homeostasis In Vitro by a WNT/ β -Catenin Dependent Mechanism.GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer.Metastatic bone disease: role of transcription factors and future targets.Lef1DeltaN binds beta-catenin and increases osteoblast activity and trabecular bone mass.Wnt/β-catenin signaling is differentially regulated by Gα proteins and contributes to fibrous dysplasia.A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.Update on Wnt signaling in bone cell biology and bone disease.Wnt signaling in bone development and disease: making stronger bone with WntsSIRT1 regulates differentiation of mesenchymal stem cells by deacetylating β-catenin.Understanding multicellular function and disease with human tissue-specific networks.Co-stimulation of the bone-related Runx2 P1 promoter in mesenchymal cells by SP1 and ETS transcription factors at polymorphic purine-rich DNA sequences (Y-repeats)BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling.Cell culture systems for studies of bone and tooth mineralization.Mesodermal fate decisions of a stem cell: the Wnt switch.Secreted frizzled related protein 1 is a target to improve fracture healing.Runx2 and bone morphogenic protein 2 regulate the expression of an alternative Lef1 transcript during osteoblast maturation.Co-activator activator (CoAA) prevents the transcriptional activity of Runt domain transcription factorsOsteocytes and WNT: the mechanical control of bone formation.Cell therapy in bone healing disordersMolecular mediators of mesenchymal stem cell biology.Wnt/β-catenin pathway regulates bone morphogenetic protein (BMP2)-mediated differentiation of dental follicle cells.β-catenin is required for taste bud cell renewal and behavioral taste perception in adult mice.Collagen 11a1 is indirectly activated by lymphocyte enhancer-binding factor 1 (Lef1) and negatively regulates osteoblast maturation.Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells.Integrated network analysis to explore the key genes regulated by parathyroid hormone receptor 1 in osteosarcoma.Predominant role of PDGF receptor transactivation in Wnt3a-induced osteoblastic cell proliferation.Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.The RhoGAP Myo9b Promotes Bone Growth by Mediating Osteoblastic Responsiveness to IGF-1.Physical activity and hypocaloric diet recovers osteoblasts homeostasis in women affected by abdominal obesity.
P2860
Q27022532-2492FC65-44DE-416C-A40E-FBF273A7EDE1Q27691363-D1E1480C-A80C-4B11-84B8-808FBBB8BFC5Q33438492-68561A2D-6F10-4DEF-B5E6-4FBEC51C426FQ33744727-387AF0B3-1239-48EE-9C69-66295175BA72Q33829414-2EBB0C5B-9377-4C85-9DAF-CF85C0249A01Q34217531-0A7BC24E-190C-450A-B905-001C4FE4DF79Q34719382-7F582CFA-E4C2-4346-9B48-E7067E3BC263Q35647471-41CF0C9A-914B-40AE-91D8-6C7D87AFA3C3Q35755034-EA6DF5B8-D1B7-41CC-BAB6-9CDDF614E217Q36083303-D4353A81-B98D-416F-9565-F47B1B2856CEQ36418026-7670BE64-C9CF-4CBF-B008-3F23C75928EAQ36685949-D61D4722-2911-44DC-B288-2840593614FCQ36790036-071494EF-F3B4-4434-8A69-7A92CAAA10C9Q37075344-9C72F1A9-7E90-49F9-B2BC-8972940342F5Q37084834-3B90D0CB-C993-4A59-ACC6-181013C7491FQ37121600-AD7E85F3-03FB-4757-AEFF-84A3A1107C1AQ37182849-D377C57C-D421-4B29-9A47-EBCE328A80E1Q37374315-DAB28B24-036B-4751-9F95-390C5AE3C8A2Q37418536-D5B6CAE8-AE48-4942-86B9-54E4F8B67133Q37421450-C6E76E55-B283-4BFF-8223-7AD3EDDB10BBQ37702067-BB4539B8-300A-4C95-A979-B5A16A1F53DDQ37909967-AA29AEC5-4DFC-46B9-96C3-8728F3BFA90CQ37962744-311E9743-7E3A-4B14-91F5-23DD84C1F4A0Q38467614-76157DAA-CC28-408C-AE91-30059687196DQ38605708-77F20EF5-8241-4515-82AC-BDBD8BF59FF8Q39279230-96B1C63E-9F8D-4DAD-B1AA-A1F534DB6502Q39801788-7ACC5095-B9D3-4CC6-BD54-9D1F67866C77Q41695202-1E76D72C-5259-4C3A-8622-6ACEA923616CQ47215693-FA7E1311-A124-4A0B-AD07-9801B78A11D2Q47330690-6AAEF433-9A83-4A18-B99A-ED480B86F360Q47740469-584352BB-3FF1-40B1-91FD-C5DF551C34CBQ48051824-E00CF278-058F-4A86-A5A6-DB2105B9F058
P2860
Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Lymphocyte enhancer-binding fa ...... ifferentiation of osteoblasts.
@en
Lymphocyte enhancer-binding factor 1
@nl
type
label
Lymphocyte enhancer-binding fa ...... ifferentiation of osteoblasts.
@en
Lymphocyte enhancer-binding factor 1
@nl
prefLabel
Lymphocyte enhancer-binding fa ...... ifferentiation of osteoblasts.
@en
Lymphocyte enhancer-binding factor 1
@nl
P2093
P2860
P356
P1476
Lymphocyte enhancer-binding fa ...... ifferentiation of osteoblasts.
@en
P2093
Andre J van Wijnen
Gary S Stein
Jennifer J Westendorf
Mario Galindo
Rachel A Kahler
P2860
P304
P356
10.1002/JCB.20702
P577
2006-04-01T00:00:00Z